Free Trial

Cipher Pharmaceuticals (CPH) Insider Trading & Ownership

Cipher Pharmaceuticals logo
C$12.98 +0.82 (+6.74%)
As of 03/27/2025 04:00 PM Eastern

Cipher Pharmaceuticals (TSE:CPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
42.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$47,215.00
Get CPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cipher Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CPH Insider Buying and Selling by Quarter

Remove Ads

Cipher Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/24/2025Harold Morton WolkinDirectorSell3,500C$13.49C$47,215.00
(Data available from 1/1/2013 forward)

CPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cipher Pharmaceuticals includes Christian Godin, and Harold Morton Wolkin. Learn more on insiders at CPH.

42.00% of Cipher Pharmaceuticals stock is owned by insiders. Learn more on CPH's insider holdings.

The following insider sold CPH shares in the last 24 months: Harold Morton Wolkin (C$47,215.00).

Insiders have sold a total of 3,500 Cipher Pharmaceuticals shares in the last 24 months for a total of C$47,215.00 sold.

Cipher Pharmaceuticals Key Executives

  • Mr. Craig J. Mull
    Interim CEO & Chairman of the Board
  • Mr. Bryan Jacobs
    Chief Financial Officer
  • Mr. Emilio Presti
    Director of Sales & Marketing


This page (TSE:CPH) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners